Stephen Ray Mitchell - 10 Aug 2023 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Reporting relationship: Director
Issuer ticker: VNDA
Reported as of: 10 Aug 2023
Net transaction value: -$39,349
SEC form: 4
Accepted by SEC: 11 Aug 2023, 16:36:31 UTC
Prior SEC filing: 12 Jun 2023
Next SEC filing: 21 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Stephen Ray Mitchell

Key filing fact

Stephen Ray Mitchell filed Form 4 for Vanda Pharmaceuticals Inc. (VNDA) on 11 Aug 2023.

Key facts

This page summarizes Stephen Ray Mitchell's Form 4 filing for Vanda Pharmaceuticals Inc. (VNDA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Aug 2023, 16:36.

Change

Previous filing in this sequence was filed on 12 Jun 2023.
Current net transaction value: -$39,349.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNDA transaction

Common Stock

Sale

Transaction value: $39,349
Shares: -6,500
Change %: -18%
Price: $6.05
Shares after: 29,328
Date: 10 Aug 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.0952, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.